View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
DOD/DODOASHA RIN: 0720-AB85 Publication ID: Spring 2022 
Title: Expanding TRICARE Access to Care in Response to the COVID-19 Pandemic 
Abstract:

This interim final rule with comment will temporarily amend the TRICARE regulation at 32 CFR part 199 by: (1) adding freestanding End Stage Renal Disease facilities as a category of TRICARE-authorized institutional provider and modifying the reimbursement for such facilities; (2) adding coronavirus 2019 (COVID-19) Immunizers who are not otherwise an eligible TRICARE-authorized provider as providers eligible for reimbursement for COVID-19 vaccines and vaccine administration; (3) and adopting Medicare New COVID-19 Treatments Add-on Payments (NTCAPs).

 

 

 
Agency: Department of Defense(DOD)  Priority: Other Significant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Final Rule Stage 
Major: No  Unfunded Mandates: No 
CFR Citation: 32 CFR 199   
Legal Authority: 5 U.S.C. 301    10 U.S.C. ch. 55   
Legal Deadline:  None
Timetable:
Action Date FR Cite
Interim Final Rule  08/00/2022 
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Small Entities Affected: No  Federalism: No 
Included in the Regulatory Plan: Yes 
RIN Data Printed in the FR: No 
Agency Contact:
Jahanbakhsh Badshah
Healthcare Program Specialist - Reimbursement
Department of Defense
Office of Assistant Secretary for Health Affairs
16401 E. Centretech Parkway,
Aurora, CO 80011
Phone:303 676-3881
Email: jahanbakhsh.badshah.civ@health.mil